Solar power is proving it can compete without government help. And that means the main criticism of solar—cost competitiveness—is history.» Read More
Oil edged downward, after surging to a record high above $90 per barrel earlier on Friday. Boone Pickens offered CNBC his insights.
Discussing leadership, motivation and career success with Jack Welch, former General Electric chairman & CEO.
Amid soaring oil prices and ballooning global fuel demand, the Bush Administration is calling on Americans to help conserve energy on a personal level.
General Motors said U.S. sales rose nearly 4% in September, boosted by incentives on its pickup trucks, while Ford Motor and Toyota Motor posted declines.
OPEC would likely hold consultations about boosting supply again if the price of oil stayed above $80 a barrel for more than 15-20 days, an OPEC source said on Tuesday.
These picks can make solid gains, but they provide much-needed protection when times are tough.Investing can be confusing. Luckily, Cramer has mapped out some road rules for all you Home Gamers trying to navigate the jungle that is Wall Street. Think of it as "Mad Money 101" –- some fundamental advice to keep in mind as you play the market. Whether you're a first time investor or a seasoned financier, it's always good to remember the basics.
CNBC Europe's Dan Scott reports from the Frankfurt Motor Show and marvels at Porsche's decision to make a hybrid SUV.
Australian infrastructure investment group Macquarie is set to team up with U.S. bank JP Morgan in a £4 billion (US$8 billion) bid battle for Britain's Southern Water, The Telegraph reported on its website.
Central bankers and politicians are in the business of confidence building. Without it, markets - financial or otherwise - do not function. Both Bush and Bernanke did what they are tasked to do...and middle America now believes it may get a reprieve on foreclosure of its mortgage and the credit markets are starting to convince themselves a September rate cut is a foregone conclusion.
Residents of Florida don’t need an anniversary to remember Katrina; they get a reminder every month in their homeowner’s insurance bill. The devastating hurricane season of 2005 caused and is still causing many insurers to either raise rates or drop coverage entirely.
Royal Dutch Shell Plc and Dow Chemical are in talks with the Iraqi government to renovate and expand a chemical plant in southern Iraq at a cost of up to $2.1 billion, the Iraqi industry minister said.
Sales of new U.S. homes unexpectedly rose 2.8 percent to an 870,000 annual sales pacein July, reversing two months of declines, and inventories eased, a Commerce Department report showed on Friday. Despite the surprising strength, some economists said the housing outlook remains grim.
With stocks in rally mode, it's appropriate to drill down for answers as well as take a look at some key sectors.
Shares in Britain's Arriva jumped 7.9 percent Tuesday on news the transport company won a contract to run the country's biggest rail franchise, Cross Country.
With heat gripping much of the U.S., "Morning Call" chatted with two utility experts about how to make some cool cash off of recent trends facing power companies.
Andrew Acheson, portfolio manager at Pioneer Independence Fund, told CNBC’s “Street Signs” that he expects the market to move higher despite concerns about the subprime loan market.
Shares in Aker Kvaerner fell 0.8% as the Norwegian government, SAAB and Investor announced they will buy a strategic stake in the Norwegian engineering group, Reuters reported.
European equity markets looked set to extend losses next week as stocks teetered at inflated price levels with little on the corporate and economic calendar to act as a positive catalyst.
Shares in Renault outperformed the CAC-40 with a 4.2%, rise as the French automaker said it was considering adding a low-cost car to its fleet to target emerging market consumers, Reuters reported.
Shares in GlaxoSmithKline fell 0.4% as the British pharmaceutical giant came under fire for allegedly misleading its shareholders about safety concerns facing its diabetes drug Avandia.